Skip to main content

Tweets

Study of NSAID use in 7747 patients hospitalized with influenza or influenza pneumonia found NSAID use was not associated with an increase in 30-day intensive care unit admission or death https://t.co/9LmFLeqJD2

Dr. John Cush RheumNow( View Tweet)

1 month ago
I have entered more patients with #COVID19 in the @rheum_covid registry in the last 3 days than I have in the last 3 months. Come on Texas- we can do better! Wear your mask, watch your distance, and help each other stay healthy #July4th @RheumNow
1 month ago
Claims data study of nearly 3 million receiving influenza vaccination shows an increased risk of subsequent subdeltoid bursitis, but incredibly low with an attributable risk was 7.78 additional bursitis per 1 million vaccinated.https://t.co/qtzd8pWk4O

Dr. John Cush RheumNow( View Tweet)

1 month ago
Pneumonia vaccination of 21461 RA pts in UK Clinical Practice Research Datalink (2000-18) finds 38.2% vaccinated; 44.3% ≥65 years, 66.4% female; 36.5% vaccinated prior to starting csDMARDs, moreso in elderly. VAX increased over time (esp 2003 to 2007) https://t.co/QTedUMWvE0

Dr. John Cush RheumNow( View Tweet)

1 month ago
PRES - Posterior reversible encephalopathy syndrome. Review of US hosp records finds 3125 cases. Rheum Dz associations include ANCA+ vasculitis (OR 9.3), PsA (4.6), Scleroderma (6.6), SLE nephritis (7.5), SLE (2.4); also renal failure, pre-/eclampsia https://t.co/uLQxU3RNuD

Dr. John Cush RheumNow( View Tweet)

1 month ago
UK population study shows fibromyalgia pts have a higher risk of Self harm (HR 2.06; 1.60,2.65)), RA (HR 1.59) & OA, but not ank spondylitis. Pain and depression are risk factors for self-harm & self harm is a key risk factor for suicide.https://t.co/vXmZKYq3Pe

Dr. John Cush RheumNow( View Tweet)

1 month 1 week ago
A Genetic Probability tool used to calculate risk of rheum Dz in 3 pt cohorts (1211 eMERGE, 245 Partners & 243 early inflam arthritis. Dx AUc: 0.69, 0.81 & 0.84. Likely dx made in 64% & r/o in 45%. ?Could be used to improve Dx accuracy in clinical practice?https://t.co/JiRIxtx3j5

Dr. John Cush RheumNow( View Tweet)

1 month 1 week ago
Rituximab (RTX)-associated autoimmune disease flare is rare and only seen in 7/185 pts (3.4%); all w/ type II mixed cryoglobulinemia vasculitis. Flare occurred a median 8 days post RTX, as acute kidney insuf, purpura with myocarditis or GI involvement https://t.co/pgvyddFnAd

Dr. John Cush RheumNow( View Tweet)

1 month 1 week ago
A federal appeals court on Wednesday upheld two patents for Enbrel (Amgen), rejecting Novartis AG’s effort to void the patents and clear the way for their etanercept biosimilar Erelzi (Sandoz). https://t.co/FsSpbM1O2j

Dr. John Cush RheumNow( View Tweet)

1 month 1 week ago
Series of 11 severe COVID-19 pts Rx w/ Anakinra. 7/11 recv anakinra w/in 36 hrs - none required ventilation. 4 got anakinra after 4days of Resp Sx & required ventilation; 1 died. Pts were SARS‐CoV‐2+, w/ fever, ferritin >1,000 ng/mL & acute resp failure. https://t.co/vegsJPrSGp

Dr. John Cush RheumNow( View Tweet)

1 month 1 week ago
66 critically ill & 13 non‐critically ill COVID‐19 were tested for multiple anti‐phospholipid (aPL)Abs. APL common (47%) in critically ill, may be transient (35‐39d post onset). Multiple medium/high levels aPLs may identify at risk for CVA or APS

Dr. John Cush RheumNow( View Tweet)

1 month 1 week ago
Schulz-Koops reports 2 #RA patients Rx with RTX who died from COVID pneumonia and ARDS. Both were older, had comorbidities (COPD, HTN, OP) and had received last RTX either 2 wks and 6 mos before COVID infection onset; both had nl IgG levels https://t.co/j043Tggdbg

Dr. John Cush RheumNow( View Tweet)

1 month 1 week ago
×